The NHS is testing a cannabis product
Share This Article:
You read the title correctly. Turns out the NHS is seeking to test a cannabis vaporiser product, and in fact the Medipen has been on sale for a year now. It has gained great reviews from those who use it to help ease their suffering from depression, anxiety, arthritis and/or fibromyalgia. According to the Independent, the cannabidiol (CBD) vaporiser is now being tested by the NHS, and the implications of that could be huge. Cannabis is currently classified as a Schedule 1 drug by the Government, meaning it’s thought to have no therapeutic value and therefore cannot be lawfully possessed or prescribed. But Medipen’s CEO believes his product – one of the most popular of its kind in the world – being tested by the NHS could aid in creating a “properly regulated cannabis market” in the UK. “We’ve recently been working very closely with a team of NHS production and regulatory support pharmacists who’ve been able to meticulously analyse our proprietary formulation for both safety and cannabinoid concentration,” managing director Jordan Owen told the Independent. “As the UK’s industry leading consumer cannabis biotechnology company, we’re excited to have set a new benchmark in providing a much-needed sense of legitimacy to the UK’s rapidly growing legal cannabis industry.
- Article continues below...
- More stories you may like...
- Talking to yourself? Here’s the science behind that little voice in your head
- This royal wedding conspiracy theory is making serious waves online
- This grumpy husky is really not here for Christmas
You might also like...
People who read this also read...